==== Front J Cardiovasc Dev Dis J Cardiovasc Dev Dis jcdd Journal of Cardiovascular Development and Disease 2308-3425 MDPI 33158304 10.3390/jcdd7040051 jcdd-07-00051 Review Muscularization of the Mesenchymal Outlet Septum during Cardiac Development https://orcid.org/0000-0002-3837-8055van den Hoff Maurice J. B. 1* https://orcid.org/0000-0002-3805-9361Wessels Andy 2 1 Department of Medical Biology, AmsterdamUMC, Location AMC, 1105AZ Amsterdam, The Netherlands 2 Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA; wesselsa@musc.com * Correspondence: m.j.vandenhoff@amsterdamumc.nl; Tel.: +1-3120-5665-405 04 11 2020 12 2020 7 4 5101 10 2020 02 11 2020 © 2020 by the authors.2020Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).After the formation of the linear heart tube, it becomes divided into right and left components by the process of septation. Relatively late during this process, within the developing outflow tract, the initially mesenchymal outlet septum becomes muscularized as the result of myocardialization. Myocardialization is defined as the process in which existing cardiomyocytes migrate into flanking mesenchyme. Studies using genetically modified mice, as well as experimental approaches using in vitro models, demonstrate that Wnt and TGFβ signaling play an essential role in the regulation of myocardialization. They also show the significance of the interaction between cardiomyocytes, endocardial derived cells, neural crest cells, and the extracellular matrix. Interestingly, Wnt-mediated non-canonical planar cell polarity signaling was found to be a crucial regulator of myocardialization in the outlet septum and Wnt-mediated canonical β-catenin signaling is an essential regulator of the expansion of mesenchymal cells populating the outflow tract cushions. myocardializationmuscularizationdifferentiationWnt signalingoutflow tract ==== Body 1. Introduction In the western world, approximately 3% of live-born children have a congenital abnormality. Of these children, a third have a cardiac defect, and of these children, again, a third have an arterial pole malformation. Over the past few decades, significant progress has been made in the understanding of the formation of the arterial pole. Professor Anderson has contributed nearly 200 publications to this effort. In this review, we will focus on one specific aspect of arterial pole formation, being the muscularization of the initially mesenchymal outlet septum. First, we will discuss the formation of the arterial pole to set the stage and then focus on myocardialization (for reviews of heart development, see [1,2]). The arterial pole of the adult heart comprises (1) the intrapericardial portion of the aorta and pulmonary trunk, (2) the valves and the surrounding myocardium, and (3) the subvalvular ventricular outlets [3,4,5,6] (Figure 1). The formation of the arterial pole of the heart starts at the end of the fourth week of human development (Carnegie Stage (CS) 10), embryonic day (E) 8 in mice, and Hamburger and Hamilton stage (HH) 11 in chickens. At this stage, the outflow tract (OFT) can be discriminated as a smooth-walled, myocardial, tube-like structure in between the site of the forming ventricular trabeculae and the border of the pericardial cavity [7,8]. At the outer surface of the heart, the proximal side of the OFT is marked by the ventriculoarterial groove and the distal side by the pericardial reflection. Up to CS15 in human, E11 in mouse, and HH23 in chicken, the OFT elongates by the addition of cardiomyocytes at its distal end. This population of cardiomyocytes is derived from the so-called second heart field (SHF) resulting from de novo differentiation of mesodermal cells into cardiomyocytes [9,10,11,12,13]. During this process, the distal myocardial border of the OFT remains at the pericardial reflection and the pericardial cavity increases in size. At the same time, the cardiomyocytes at the proximal side of the OFT differentiate into ventricular cardiomyocytes, contributing to the right ventricle and interventricular septum [14,15]. Intriguingly, at the outer surface of the heart, the ventriculoarterial groove still marks the proximal site of the OFT, suggesting that the cells that form this groove are constantly changing. With the formation of the right ventricle, also the interventricular groove on the outer surface of the heart becomes apparent, marking the position of the forming interventricular septum. With development of the right ventricle, the distance between the ventriculoarterial and interventricular grooves increases in size. After CS15 (sixth week of human development, HH23 in chicken, and E11 in mouse), the OFT increases further in length due to the addition of non-myocytes to its distal border. As a consequence, the distal myocardial border of the heart is no longer found at the level of the pericardial reflection. This non-myocardial portion is referred to as the non-myocardial OFT and will become the intrapericardial portion of the aorta and pulmonary trunk. With further development, the non-myocardial OFT increases in length and the myocardial OFT becomes (relatively) shorter. Although most of the OFT myocardium differentiates into the right ventricular myocardium, a portion remains as OFT myocardium, supporting the semilunar valves and the smooth-walled subvalvular myocardium [14,16,17]. 2. Septation of the Arterial Pole The OFT comprises not only cardiomyocytes but also an inner layer of endocardial cells. The myocardium and endocardium are separated by a layer of extracellular matrix (ECM), referred to as a cardiac jelly. Prior to the onset of the formation of the non-myocardial OFT, the cardiac jelly of the OFT forms two major spiraling cushions, the parietal and septal OFT cushions (also referred to as OFT ridges). The cushions swell and fuse midway, separating the left and right bloodstreams. The fusion of the cushions starts from the distal side and proceeds proximally, i.e., in the direction of the ventricles. During this phase of development, the non-myocardial OFT forms (as described above) and it is important to note that no cardiac jelly is found in between the endocardium and the wall of the non-myocardial OFT. The lumen of the non-myocardial OFT connects the OFT lumen with the lumen of the aortic sac and the pharyngeal arch arteries that are located outside the pericardial cavity. The pharyngeal arch artery system shows extensive remodeling, which we will not discuss as it is beyond the scope of this review. Of relevance for this review is, however, that the left fourth pharyngeal arch artery will contribute to the aorta, and the left and right sixth pharyngeal artery to the left and right pulmonary artery, respectively. From the dorsal wall of the aortic sac, in between the origins of the fourth and the sixth pharyngeal arch arteries, the roof bulges into the lumen of the aortic sac at CS16 to form the aorticopulmonary septum (APS). The APS then expands in the direction of the fused OFT cushions. With its lengthening and the eventual fusion of its tip with the distal border of the fused OFT cushions, the aortic and pulmonary bloodstreams are separated [4,5,18]. During subsequent development, the non-myocardial OFT is separated into the intrapericardial portion of the aorta and pulmonary trunk. As a consequence, the APS is no longer recognized as a septum, but materially contributes to the facing walls of the intrapericardial portion of the aorta and pulmonary trunk. The separation of the arterial pole continues in the direction of the ventricles. The septation of the distal portion of the OFT results in completing the myocardial cuffs that support the forming semilunar valves. At this stage of development, the coronary orifices are still embedded within the myocardium. With ongoing development, the distal myocardial border further decreases to a level below the coronary orifices, approximately halfway the semilunar cusps. The disappearance of this last section of the myocardium is not only due to differentiation of the OFT myocardium into the ventricular myocardium but also due to apoptosis [14,19,20]. The extent of this process is different in the aortic and pulmonary segment, which is probably responsible for the fact that the primordia of the valves and, eventually, the formed aortic and pulmonary valves are no longer found at the same level but rather tilted with respect to each other. As a consequence of these changes, the myocardial cuff of the pulmonary outlet facing the aorta is now recognized as the freestanding muscular infundibulum. Thus, this free-standing muscular infundibulum is simply a myocardial sleeve supporting the leaflets of the pulmonary valve. It is only below the level of the aortic semilunar valves and distally of the membranous septum that a muscular septum persists. 3. Myocardializaton of the Outlet Septum Prior to the onset of fusion of the OFT cushions, they become populated by mesenchymal cells. In the proximal part of the OFT, the cushions, the mesenchymal cells are mainly derived from the endocardium, as a result of endocardial to mesenchymal transition (endMT) [21]. In the distal as well as the middle part of the OFT, the cushions are primarily populated by mesenchymal cells that originate from the cardiac neural crest. These cardiac neural crest cells form a condensed pillar in both cushions located in the middle part of the OFT and become dispersed and intermingle with the endocardially-derived mesenchymal cells in the cushions of the proximal part of the OFT [16,22,23,24]. When the cushions in the proximal OFT are fused, the dispersed neural crest cells enter into apoptosis and the cardiomyocytes of the initially smooth-walled myocardium start to form protrusions into the flanking mesenchyme [16,20,25,26] (Figure 2). While invading the mesenchyme, they never lose their contact with the flanking OFT myocardium [16,27,28,29]. This process is referred to as myocardialization and continues until the entire outlet septum is myocardial. In the mouse, myocardialization takes place between E11 and E15 [30], in chicken between HH28 and HH38 [28], and in human between CS17 and CS23 [17]. 4. Congenital Cardiac Abnormalities and Absence of Myocardializaton Now that we have described the process of myocardialization, there are two (related) questions that need to be addressed: What would be the consequence of failure of myocardialization to take place? Are there congenital cardiac malformations that could be attributed to abnormal myocardialization of the proximal OFT? If cardiac formation was normal and only myocardialization was absent, one would expect to find a fibrous continuity between the leaflets of the aortic and pulmonary semilunar valves, which are positioned at the same level, and a mesenchymal outlet septum in the formed heart. A congenital cardiac abnormality resembling these features is the doubly committed ventricular septal defect (VSD), the rarest form of VSD. In this situation, there is a fibrous continuity between the aortic and pulmonary semilunar valves and a VSD situated immediately below both the aortic and pulmonary semilunar valves, i.e., in the position of the outlet septum. In this situation, the position of the pulmonary and aortic outlets can be normal, or one or both can override the ventricular septum. In case the VSD is committed to either the aortic or the pulmonary outlet, the muscular freestanding infundibulum is formed. Another situation to be considered is the double outlet right ventricle (DORV). DORV is a very heterogenous group, which has in common the fact that both the aorta and pulmonary trunk emanate from the right ventricle. In addition, there is an obligatory communication between the left and right ventricle, of which a small portion has a doubly committed VSD. In case of a transposition of the great arteries, the connection of the aorta and pulmonary trunk is discordant with respect to the ventricles, but the muscular freestanding infundibulum and muscular outlet septum are formed. In case the OFT is not septated at all, as is the case in a common arterial trunk (CAT), it is evident that the freestanding muscular infundibulum and the muscular outlet septum are not formed. In CAT, absence of myocardialization is most probably secondary [3,31,32]. 5. Mechanism of Cardiac Muscle Formation in the Outlet Septum: Muscularization vs. Differentiation The mechanism by which the outlet septum changes from a mesenchymal into a myocardial structure is still contentious. Initially, we have described muscularization of the outlet septum as the result of migration of existing proximal OFT cardiomyocytes into the flanking mesenchyme, a process that we named “myocardialization” [28]. Migration was proposed based on the following in vivo and in vitro observations. (i) Prior to the onset of myocardialization in vivo, the myocardial wall flanking the cushion mesenchyme is smooth. The first signs of myocardialization are the appearance of protrusions from the proximal OFT myocardium into the flanking cushion mesenchyme. With ongoing development, the cardiomyocytes that intermingle with the cushion mesenchyme remain slender and show projections. (ii) Culturing chicken or mouse OFT explants (of stages that do show myocardialization in vivo) on a thick 3D collagen lattice showed spontaneous 3D network formation of cardiomyocytes below and surrounding the explant in the collagen lattice. OFT explants prepared of stages prior to myocardialization in vivo, distal OFT explants, or ventricular explants of any developmental stage did not show network formation when tested in this assay. When OFT explants prepared of stages prior to myocardialization in vivo were cultured in medium conditioned by OFT explants that do form a myocardial network in the collagen, they can be induced to do so. This conditioned medium was not able to induce myocardialization in ventricular or distal OFT explants. Moreover, medium conditioned by ventricular explants did not induce myocardial network formation of young OFTs [28,30]. These findings support the hypothesis that the myocardialization-inducing substance is a factor secreted by cells of the OFT at stages when myocardialization is observed in vivo. In an attempt to further characterize myocardialization, proximal OFT cushion mesenchyme was cultured in the myocardialization assay. Cushion mesenchyme did not form cardiomyocytes or networks. However, when proximal OFT cushion mesenchyme was cultured in medium conditioned by OFT explants that do form myocardial networks in vivo, cardiomyocytes were formed. This effect was found to be specific for the proximal OFT cushion mesenchyme, because explants of the non-myocardial OFT were not able to do so [30]. Both in vitro and in vivo, the expression of myosin heavy chain in the cells forming the myocardial network is proceeded by alpha smooth muscle actin [17,33,34] or calponin [35] expression, being suggestive of a differentiation process. It should, however, be noted that smooth muscle actin expression has also been used as a marker for migration [36]. Taken together, these findings suggest that muscularization of the outlet septum might not only be the result of myocardialization but that differentiation of the proximal OFT cushion mesenchyme may also contribute. If cardiomyocytes are indeed newly formed as a result of differentiation, one needs to consider the origin of the differentiating cells. The mesenchyme of the outlet septum is derived from the endocardium, cardiac neural crest [23,24], and the epicardium (unpublished observations). The epicardially derived mesenchyme seems to be an unlikely cell source for myocardial differentiation in the context of myocardialization of the OFT as epicardially derived cells arrive after the onset of muscularization in the outlet septum. Neural crest-derived mesenchyme can also be excluded because these cells undergo apoptosis prior to the onset of the muscularization [16,25,37]. Furthermore, the non-myocardial OFT, which is largely derived from cardiac neural crest cells, is not able to form myocardial networks in the in vitro 3D collagen assay [28]. Taken together, this points to the endocardially derived mesenchyme as a possible source of newly differentiated cardiomyocytes. This idea is supported by the observations that (i) the endocardial derived cells are abundantly present at the proper time and location and (ii) that endocardial cells are derived from the cardiogenic mesoderm [15,38,39,40]. Importantly, however, genetically tracing the endocardial cell lineage using the Tie2-Cre; ROSA26 model does not identify cardiomyocytes that are of endocardial origin. The latter finding suggests that if any muscularizing cells in the outlet septum have formed as a result of a process of myocardial differentiation, it is not as a result of differentiation of any cell type in the OFT that we know of to date. 6. Molecular Regulation of Myocardium Formation in the Outlet Septum The in vitro experiments with conditioned medium discussed above suggest that muscularization of the outlet septum might be induced by a secreted soluble factor. Efforts to identify the nature of this factor from conditioned medium have not yet been successful. In a candidate gene approach, a large set of growth factors was tested for their ability to induce myocardial network formation in early OFT explants. These experiments showed that, when tested individually, activin A, angiotensin II, BMP2, BMP4, cardiotrophin, endothelin-1, -2, -3, FGF2, IGF-II, neurotrophin-3, osteopontin, or TGFβ1 were not able to induce myocardial network formation. However, TGFβ2 and TGFβ3 were, in a concentration-dependent manner, able to induce the formation of myocardial networks [41]. In studies analyzing mesenchyme formation in atrioventricular explants, TGFβ2 or TGFβ3 have been identified as important regulators of endMT and to regulate the migration of the mesenchymal cells into the acellular cushions (for review, see [42]). In vitro analyses also uncovered a role for the TGFβ receptors in the regulation of endEMT (for review, see [43]). A difference in the spatiotemporal expression pattern of the TGFβ receptors might underlie the difference in the effect of TGFβ2 and TGFβ3 in myocardialization. However, this idea has, to the best of our knowledge, not been pursued. In mice, deletion of TGFβ2 [44,45] was found to affect the development of the OFT to different degrees. In several of the TGFβ2 knockout embryos, the cushions in the proximal OFT were underdeveloped, had not fused, and were not muscularized. When OFT explants of wildtype and TGFβ2 knockout mice were studied in the 3D collagen myocardialization assay, no difference in myocardial network formation was found [46]. These results suggest that aberrant myocardialization is not a direct effect of the absence of TGFβ2, but rather a secondary effect related to mesenchyme formation in the cushions. Although, in the first report describing TGFβ3 knockout mice, cardiac defects were not reported [47], a recent study reported a small fraction of TGFβ3 knockout embryos in which the OFT cushions were not fused or myocardialized [48]. The abundance of mesenchymal cells in the OFT cushions seems to be of relevance in the regulation of myocardialization, because the level of dysregulation of endMT in the TGFβ2 and TGFβ3 knockout models is different. Another example of a mouse model with abnormal cushion development and failure of muscularization is the neurofibromin 1 (Nf 1) knockout mouse in which the OFT cushions are hyperplastic and are not muscularized [49]. Interestingly, in the friend-of-GATA 2 (Fog2) knockout mouse, the proximal parts of the OFT cushions are hyperplastic and muscularization does take place [50]. The major difference between these latter two mouse models seems to be the extent of apoptosis of mesenchyme in the proximal part of the OFT. During normal development, the dispersed neural crest cells in the proximal part of the OFT cushions enter into apoptosis prior to myocardialization. In the Fog2 knockout mouse, the level of apoptosis appears normal, perhaps even elevated, whereas in the Nf1 knockout mouse, the level is significantly decreased. Further analysis of the Nf1 knockout mouse showed that the OFT cushions are enlarged due to expansion of the endocardially derived cell population, which seems to hamper the invasion of neural crest cells [49]. Thus, the absence of apoptosis in the Nf1 knockout mice is due to the absence of the neural crest cells rather than a dysregulation of apoptosis. The presence of the dispersed neural crest cells and their subsequent apoptosis seems to be an important aspect in the regulation of myocardialization. Deletion of semaphorin-3c (Sema3c) from the neural crest cells or absence of its receptor neuropilin-1 (Nrp1) interferes with the invasion of the neural crest cells. In this model, the mesenchymal cells in the cushions in the proximal part of the OFT are disorganized and myocardialzation is absent. Interestingly, the cardiac muscle cells in these mutant mice show the phenotypic characteristics of myocardialization in the distal portion of the OFT [51]. Ectopic myocardialization in the distal OFT was also found in the Trisomy 16 mouse [52]. In this study, ectopic myocardialization was suggested to be associated with the location of the invading cardiac neural crest cells. In connexin 43 (Cx43) knockout mice, which display OFT and right ventricular abnormalities, a reduction in the number of invading cardiac neural crest cells was observed [53]. In a detailed analysis, myocardialization was found to be affected, as the cardiomyocytes of the proximal part of the OFT were found to form relatively late and only a few projections into the cushion mesenchyme were observed. Furthermore, the myofibrillar structure in these cardiomyocytes was disorganized [54]. A similar defect was observed in the loop-tail mouse. In a series of manuscripts by the Henderson group, it was established that in these mice, Vangl2, expressed in the cardiomyocytes, was mutated. Vangl2 is a component of the Wnt-planar cell polarity (Wnt/PCP) signaling pathway [55]. Downstream of Vangl2, RhoA and Rock1 were found to be required for the polarization and movement of the cardiomyocytes into the OFT cushions [56,57,58]. Disrupting the interaction of Prickle1 with Vangl2 was found to lead to similar abnormalities [59]. Interestingly, Cx43 expression also seems to be linked to the Wnt/PCP pathway through Rock1, which is downregulated in Cx43 KO mice [60]. It has not yet been established which Wnt ligand activates the Vangl2-mediated signaling pathway. Based on the analysis of genetically modified mice, Wnt5a and Wnt11 are candidates. In Wnt11 knockout mice, transposition of the great arteries (TGA) is observed. An in-depth analysis revealed that the freestanding muscular infundibulum and muscular outlet septum were not formed [61,62] due to altered polarity of the cardiomyocytes of the proximal part of the OFT [62]. Wnt11 expression is regulated through the cooperative action of Pitx2 and β-catenin on its proximal promoter in cardiomyocytes. Wnt11, in turn, activated TGFβ2 through JNK and ATF2 [62], pointing to an indirect effect on endEMT. Wnt5a knockout mice show a large array of abnormalities, including common arterial trunk (CAT). Expression of Wnt5A in the mesodermal cells of the pharyngeal arches and in the myocardium of the OFT [63] was found to regulate the migration of cardiac neural crest cell into the OFT. The myocardial expression of Ror 1 and Ror 2 receptors [64], which propagate Wnt5a mediated PCP signaling [65], is suggestive of a role in the regulation of myocardialization. This idea is underscored by the observations that Ror1/Ror2 double knockout mice display TGA and a membranous VSD, whereas Ror1 knockout mice have a normal heart and Ror2 knockout mice have a membranous VSD [66,67]. Wnt5a was also found to activate Wnt/β-catenin-mediated signaling through Frizzled-4 [68]. Interestingly, a mutation screen identified Frizzled-4 in a mouse line showing a large VSD in the region of the outlet septum. Further analysis of this mouse line showed that the VSD was due to aberrant migration of the cardiac neural crest cells into the OFT [69]. In Dishevelled-2 (Dvl2) knockout mice, perturbed neural crest migration into the OFT was observed, resulting in CAT and DORV [70]. This observation should be interpretated with caution as in mouse and human, three homologous Dvl genes are found that are expressed abundantly. Knockout analysis has shown that they have complementary and unique functions. Dvl was found to activate both Wnt/β-catenin and Wnt/PCP signaling pathways. The specificity of the signaling is regulated through different domains in the Dvl protein and interacting partners and as such affect different biological effects [55]. Conditional removal of focal adhesion kinase (FAK), which is also a component of Wnt/β-catenin-mediated signaling, from the cardiomyocytes using Nkx2.5-Cre results in an overriding aorta or DORV. In this model, cardiomyocytes do not invade the proximal OFT cushions, and in in vitro assays, it was observed that cardiomyocytes isolated from homozygous FAK knockout mice were not able to migrate. Further analysis of the underlaying signaling pathways identified FAK-dependent CAS (Crk-associated substrate) activation as an essential regulator of polarized myocyte movement [71]. The involvement of FAK-dependent CAS in the regulation of myocardialization links Wnt/β-catenin-mediated signaling with integrin-mediated signaling. Integrins are the main receptors transferring extracellular matrix (ECM) information into the cells. Thus far, altered integrin expression has not been considered in the context of myocardialization. The ECM is not only of importance for the migration of cardiomyocytes into the OFT cushions, but also for the population of the cushions by mesenchymal cells. The mesenchymal cells of the proximal OFT cushions might not only directly but also indirectly affect myocardialization through ECM modulation. In this respect, it is interesting to note that both in vitro and in vivo analyses showed that low levels of fibronectin are required for intermingling of cardiomyocytes and mesenchymal cells, whereas high levels of fibronectin inhibit their intermingling [72]. Moreover, altering the relative abundance of splice variants of the chondroitin sulfate proteoglycan versican was observed to result in underdeveloped OFT cushions and absence of myocardialization [73]. These findings point to a role of the ECM in supporting or regulating myocardialization and warrant further analysis. Taken together, the regulation of muscularization of the cushions in the proximal OFT is a complex process in which Wnt and TGFβ signaling play essential roles and where the interaction between cardiomyocytes, endocardial derived cells, neural crest cells, and the extracellular matrix seems to be essential. 7. Muscularization of the Dorsal Mesenchymal Protrusion Although this review primarily deals with the process of muscularization of the outflow tract, it seems appropriate to also briefly pay attention to one other part of the developing heart where a mesenchymal structure eventually becomes muscularized. This structure is the dorsal mesenchymal protrusion (DMP), which plays a crucial role in atrioventricular septation together with two other mesenchymal structures: the AV cushions and the mesenchymal cap on the leading edge of the primary atrial septum (for review, see [74]). The DMP, which is sometimes also referred to as the spina vestibula or the vestibular spine, is a second heart field-derived structure [75,76]. In the early stages of atrioventricular septation (in the mouse between E9.5 and E10.5), the DMP protrudes into the common atrium, using the dorsal mesocardium as its portal of entry. It will eventually fuse with the other mesenchymal component and, as part of the AV mesenchymal complex, sits on top of the fused AV cushions, forming the base of the atrial septal complex. It is not until E13 in the mouse that the DMP becomes muscularized and becomes the inferior muscular rim of the atrial septum. Muscularization of the DMP was initially considered to take place by myocardialization [29,30,77]. However, more recent work from us and others shows that the DMP becomes muscularized as a result of a mesenchymal-to-myocardial differentiation of SHF-derived mesenchyme [75,78,79,80,81,82]. 8. Concluding Remarks During cardiac septation, a mesenchymal outlet septum is formed in the outflow tract by the fusion of the OFT cushions. During subsequent development, this mesenchymal outlet septum becomes muscularized by the process of myocardialization, which is defined as the migration of existing cardiomyocytes into flanking mesenchyme. Detailed analyses of myocardialization using genetically modified mice and in vitro assays suggest that the relative contribution of each cell population and the interaction between endocardially derived mesenchymal cells, cardiac neural crest-derived mesenchymal cells, and cardiomyocytes in the outlet septum is essential for the correct orchestration of the transition of the cardiomyocytes into a migratory phenotype and their migration into the adjacent cushion mesenchyme. The migration of cardiomyocytes into the mesenchyme is mediated by the Wnt non-canonical planar cell polarity signaling and the expansion of the mesenchymal cells in the OFT cushions by Wnt-mediated canonical β-catenin signaling. In addition, the TGFβ signaling pathway seems to be important in the regulation of myocardialization by affecting the mensenchymal cell population of the cushions. While the importance of muscularization/myocardializion for proper heart development is evident, it is tempting to speculate about the importance of this mechanism in a broader context. A myocardial infarction results in loss of cardiomyocytes and subsequent replacement by fibrous scar tissue. The limited inherent regenerative capacity of the adult cardiomyocytes prevents the repopulation of the scar (for review, see [83]). As a therapeutic approach to repopulating the fibrous scar and, hence, preserving cardiac function, insight into the mechanisms that regulate myocardialization in the embryonic heart may also be of relevance in designing strategies to induce healthy cardiomyocytes from the border zone of the infarct to migrate into the scar and improve cardiac function. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Author Contributions M.J.B.v.d.H. and A.W. have been together involved in the conceptualization, writing—original draft preparation, review and editing. Both authors have read and agreed to the published version of the manuscript. Funding Work presented in this contribution was partly supported by the Netherlands Heart Foundation through the Molecular Cardiology Program on Heart Failure (MvdH) and the National Institutes of Health (NIH) grant R01HL122906 (AW). Conflicts of Interest The authors declare no conflict of interest. Figure 1 Images showing the distal myocardial border in the adult human heart. (A) shows an adult human heart in which windows were cut from the right and left ventricles to expose the interior structures. The dotted line indicates the distal myocardial border on the pulmonary trunk. (B) shows a detail of the windowed right ventricle focusing on the area of the outlet septum. (C) shows the relation of the large vessels leaving the heart. Note the difference in the level of the semilunar valves and the myocardial sleeve on the pulmonary trunk. The large vessels are cut at the distal myocardial border, showing the level of the myocardial border in relation to the semilunar valves. Abbreviations: Ao: aorta; fmi: freestanding muscular infundibulum; LA: left atrium; LV: left ventricle; OS: outlet septum; pt: pulmonary trunk; RA: right atrium; RV: right ventricle; svsm: semilunar valve supporting myocardium; vs: ventricular septum. Figure 2 Micrographs of immunohistochemically stained sections of mouse embryos at the level of the outlet septum. The cardiomyocytes expressing ventricular myosin heavy chain are identified by their brown/red staining. (A) shows a section of the arterial pole at embryonic day (E) 13.5. Note the cardiomyocytes that protrude from the OFT myocardium into the mesenchyme of the outlet septum (arrow heads), being a hallmark of the onset of myocardialization. At E14.5 (B), the mesenchymal outlet septum is muscularized and becomes smaller. At E15.5 (C), only a small part of the mesenchymal outlet septum is found, and at E16.5 (D), the entire outlet septum is muscularized. The bar indicates a length of 100 µm. Abbreviations: Ao: aorta; LA: left atrium; OS: outlet septum; pt: pulmonary trunk; RA: right atrium; RV: right ventricle. ==== Refs References 1. Sylva M. van den Hoff M.J.B. Moorman A.F.M. Development of the human heart Am. J. Med. Genet. Part A 2014 164A 1347 1371 10.1002/ajmg.a.35896 23633400 2. Buijtendijk M.F.J. Barnett P. van den Hoff M.J.B. Development of the human heart Am. J. Med. Genet. Part C Semin. Med. Genet. 2020 184 7 22 10.1002/ajmg.c.31778 32048790 3. Anderson R.H. Freedom R.M. Normal and abnormal structure of the ventriculo-arterial junctions Cardiol. Young 2005 15 Suppl. 1 3 16 10.1017/S1047951105000971 4. Anderson R.H. Brown N.A. Webb S. Chaudhry B. Henderson D. Moorman A.F.M. Morphology of the Developing Cardiac Outflow Tract Shaping the Heart in Development and Disease Mikhailov A.T. Torrado M. Transworld Research Network Kerala, India 2010 5. Anderson R.H. Chaudhry B. Mohun T.J. Bamforth S.D. Hoyland D. Phillips H.M. Webb S. Moorman A.F. Brown N.A. Henderson D.J. Normal and Abnormal Development of the Intrapericardial Arterial Trunks in Man and Mouse Cardiovasc. Res. 2012 95 108 115 10.1093/cvr/cvs147 22499773 6. Anderson R.H. Mori S. Spicer D.E. Brown N.A. Mohun T.J. Development and Morphology of the Ventricular Outflow Tracts World J. Pediatr. Congenit. Hear. Surg. 2016 7 561 577 10.1177/2150135116651114 27587491 7. Moorman A.F.M. Anderson R.H. Christoffels V.M. The ballooning model for formation of the cardiac chambers Heart Development and Regeneration Harvey R.P. Rosenthal N. Academic Press San Diego, CA, USA 2007 8. Moorman A.F.M. Christoffels V.M. Cardiac chamber formation: Development, genes and evolution Physiol. Rev. 2003 83 1223 1267 10.1152/physrev.00006.2003 14506305 9. Kelly R.G. Brown N.A. Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm Dev. Cell 2001 1 435 440 10.1016/S1534-5807(01)00040-5 11702954 10. Mjaatvedt C.H. Nakaoka T. Moreno-Rodriguez R.A. Norris R.A. Kern M.J. Eisenberg C.A. Turner D. Markwald R.R. The outflow of the heart is recruited from a novel heart forming field Dev. Biol. 2001 238 97 109 10.1006/dbio.2001.0409 11783996 11. Waldo K.L. Kumiski D.H. Wallis K.T. Stadt H.A. Hutson M.R. Platt D.H. Kirby M.L. Conotruncal myocardium arises from a secondary heart field Development 2001 128 3179 3188 11688566 12. Buckingham M. Meilhac S. Zaffran S. Building the mammalian heart from two sources of myocardial cells Nat. Rev. Genet. 2005 6 826 837 10.1038/nrg1710 16304598 13. Moorman A.F.M. Christoffels V.M. Anderson R.H. van den Hoff M.J.B. The heart-forming fields: One or multiple? Philos. Trans. R. Soc. B 2007 362 1257 1265 10.1098/rstb.2007.2113 14. Rana M.S. Horsten N.C.A. Tesink-Taekema S. Lamers W.H. Moorman A.F.M. van den Hoff M.J.B. Trabeculated right ventricular free wall in the chicken heart forms by ventricularization of the myocardium initially forming the outflow tract Circ. Res. 2007 100 1000 1007 10.1161/01.RES.0000262688.14288.b8 17347476 15. Verzi M.P. McCulley D.J. De V.S. Dodou E. Black B.L. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field Dev. Biol. 2005 287 134 145 10.1016/j.ydbio.2005.08.041 16188249 16. Ya J. van den Hoff M.J. de Boer P.A. Tesink-Taekema S. Franco D. Moorman A.F. Lamers W.H. Normal development of the outflow tract in the rat Circ. Res. 1998 82 464 472 10.1161/01.RES.82.4.464 9506707 17. Sizarov A. Lamers W.H. Mohun T.J. Brown N.A. Anderson R.H. Moorman A.F. Three-dimensional and molecular analysis of the arterial pole of the developing human heart J. Anat. 2012 220 336 349 10.1111/j.1469-7580.2012.01474.x 22296102 18. Rana M.S. Sizarov A. Christoffels V.M. Moorman A.F. Development of the Human Aortic Arch System Captured in an Interactive Three-Dimensional Reference Model Am. J. Med. Genet. A 2014 164 1372 1383 10.1002/ajmg.a.35881 23613216 19. Watanabe M. Choudry A. Berlan M. Singal A. Siwik E. Mohr S. Fisher S.A. Developmental remodeling and shortening of the cardiac outflow tract involves programmed cell death Development 1998 125 3809 3820 9729489 20. van den Hoff M.J.B. van den Eijnde S.M. Virágh S. Moorman A.F.M. Programmed cell death in the developing heart Cardiovasc. Res. 2000 45 603 620 10.1016/S0008-6363(99)00401-0 10728382 21. Wirrig E.E. Snarr B.S. Chintalapudi M.R. O’Neal J.L. Phelps A.L. Barth J.L. Fresco V.M. Kern C.B. Mjaatvedt C.H. Toole B.P. Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development Dev. Biol. 2007 310 291 303 10.1016/j.ydbio.2007.07.041 17822691 22. Waldo K. Miyagawa-Tomita S. Kumiski D. Kirby M.L. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: Aortic sac to ventricular septal closure Dev. Biol. 1998 196 129 144 10.1006/dbio.1998.8860 9576827 23. de Lange F.J. Moorman A.F.M. Anderson R.H. Manner J. Soufan A.T. de Gier-de Vries C. Schneider M.D. Webb S. van den Hoff M.J.B. Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves Circ. Res 2004 95 645 654 10.1161/01.RES.0000141429.13560.cb 15297379 24. Jiang X. Rowitch D.H. Soriano P. McMahon A.P. Sucov H.M. Fate of the mammalian cardiac neural crest Development 2000 127 1607 1616 10725237 25. Cheng G. Wessels A. Gourdie R.G. Thompson R.P. Spatiotemporal and tissue specific distribution of apoptosis in the developing chick heart Dev. Dyn. 2002 223 119 133 10.1002/dvdy.1244 11803575 26. Poelmann R.E. Gittenberger-de Groot A.C. Apoptosis as an instrument in cardiovascular development Birth Defects Res. C Embryo Today. 2005 75 305 313 10.1002/bdrc.20058 16425248 27. Lamers W.H. Wessels A. Verbeek F.J. Moorman A.F.M. Virágh S. Wenink A.C.G. Gittenberger-de Groot A.C. Anderson R.H. New findings concerning ventricular septation in the human heart. Implications for maldevelopment Circulation 1992 86 1194 1205 10.1161/01.CIR.86.4.1194 1382888 28. van den Hoff M.J.B. Moorman A.F.M. Ruijter J.M. Lamers W.H. Bennington R.W. Markwald R.R. Wessels A. Myocardialization of the cardiac outflow tract Dev. Biol. 1999 212 477 490 10.1006/dbio.1999.9366 10433836 29. Kruithof B.P.T. van den Hoff M.J.B. Wessels A. Moorman A.F.M. Cardiac muscle cell formation after development of the linear heart tube Dev. Dyn. 2003 227 1 13 10.1002/dvdy.10269 12701094 30. van den Hoff M.J.B. Kruithof B.P.T. Moorman A.F.M. Markwald R.R. Wessels A. Formation of myocardium after the initial development of the linear heart tube Dev. Biol. 2001 240 61 76 10.1006/dbio.2001.0449 11784047 31. Anderson R.H. Ho S.Y. Wilcox B.R. The surgical anatomy of ventricular septal defect part IV: Double outlet ventricle J. Card. Surg. 1996 11 2 11 10.1111/j.1540-8191.1996.tb00002.x 8775329 32. McCarthy K.P. Ching Leung P.K. Ho S.Y. Perimembranous and muscular ventricular septal defects—Morphology revisited in the era of device closure J. Interv. Cardiol. 2005 18 507 513 10.1111/j.1540-8183.2005.00093.x 16336433 33. Colas J.F. Lawson A. Schoenwolf G.C. Evidence that translation of smooth muscle alpha-actin mRNA is delayed in the chick promyocardium until fusion of the bilateral heart-forming regions Dev. Dyn. 2000 218 316 330 10.1002/(SICI)1097-0177(200006)218:2<316::AID-DVDY6>3.0.CO;2-8 10842359 34. Kruithof B.P.T. van den Hoff M.J.B. Tesink-Taekema S. Moorman A.F.M. Recruitment of intra- and extracardiac cells into the myocardial lineage during mouse development Anat. Rec. Adv. Integr. Anat. Evol. Biol. 2003 271 303 314 10.1002/ar.a.10033 35. Moralez I. Phelps A. Riley B. Raines M. Wirrig E. Snarr B. Jin J.-P. van den Hoff M.J.B. Hoffman S. Wessels A. Muscularizing tissues in the endocardial cushions of the avian heart are characterized by the expression of h1-calponin Dev. Dyn. 2006 235 1648 1658 10.1002/dvdy.20738 16502418 36. Okagawa H. Markwald R.R. Sugi Y. Functional BMP receptor in endocardial cells is required in atrioventricular cushion mesenchymal cell formation in chick Dev. Biol. 2007 306 179 192 10.1016/j.ydbio.2007.03.015 17449024 37. Poelmann R.E. Mikawa T. Gittenberger-de Groot A.C. Neural crest cells in outflow tract septation of the embryonic chicken herat: Differentiation and apoptosis Dev. Dyn. 1998 212 373 384 10.1002/(SICI)1097-0177(199807)212:3<373::AID-AJA5>3.0.CO;2-E 9671941 38. Sun Y. Liang X. Najafi N. Cass M. Lin L. Cai C.L. Chen J. Evans S.M. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells Dev. Biol. 2007 304 286 296 10.1016/j.ydbio.2006.12.048 17258700 39. Cai C.L. Liang X. Shi Y. Chu P.H. Pfaff S.L. Chen J. Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart Dev. Cell 2003 5 877 889 10.1016/S1534-5807(03)00363-0 14667410 40. Stanley E.G. Biben C. Elefanty A. Barnett L. Koentgen F. Robb L. Harvey R.P. Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3’UTR-ires-Cre allele of the homeobox gene Nkx2-5 Int. J. Dev. Biol. 2002 46 431 439 12141429 41. van den Hoff M.J.B. Kruithof B.P.T. Wessels A. Markwald R.R. Moorman A.F.M. Regulation of myocardium formation after the initial development of the linear heart tube Cardiovascular Development and Congenital Malformations Molecular and Genetic Mechanisms Artman M. Benson D.W. Srivastava D. Nakazawa M. Blackwell Publishing, Inc. Malden, MA, USA 2005 37 40 42. Mercado-Pimentel M.E. Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart Cells Tissues Organs 2007 185 146 156 10.1159/000101315 17587820 43. Doetschman T. Barnett J.V. Runyan R.B. Camenisch T.D. Heimark R.L. Granzier H.L. Conway S.J. Azhar M. Transforming growth factor beta signaling in adult cardiovascular diseases and repair Cell Tissue Res. 2012 347 203 223 10.1007/s00441-011-1241-3 21953136 44. Sanford L.P. Ormsby I. Gittenberger-de Groot A.C. Sariola H. Friedman R. Boivin G.P. Cardell E.L. Doetschman T. TGFb2 knockout mice have multiple developmental defects that are non-overlapping with other TGFb knockout phenotypes Development 1997 124 2659 2670 9217007 45. Bartram U. Molin D.G. Wisse L.J. Mohamad A. Sanford L.P. Doetschman T. Speer C.P. Poelmann R.E. Gittenberger-de Groot A.C. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-ß2-knockout mice Circulation 2001 103 2745 2752 10.1161/01.CIR.103.22.2745 11390347 46. Kruithof B.P.T. Myocardium Formation after the Initial Development of the Linear Heart Tube Ph.D. Thesis University of Amsterdam Amsterdam, The Netherlands 2003 47. Proetzel G. Pawlowski S.A. Wiles M.V. Yin M. Boivin G.P. Howles P.N. Ding J. Ferguson M.W. Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion Nat. Genet. 1995 11 409 414 10.1038/ng1295-409 7493021 48. Chakrabarti M. Al-Sammarraie N. Gebere M.G. Bhattacharya A. Chopra S. Johnson J. Pena E.A. Eberth J.F. Poelmann R.E. Gittenberger-de Groot A.C. Transforming Growth Factor Beta3 is Required for Cardiovascular Development J. Cardiovasc. Dev. Dis. 2020 7 19 10.3390/jcdd7020019 49. Lakkis M.M. Epstein J.A. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart Development 1998 125 4359 4367 9778496 50. Flagg A.E. Earley J.U. Svensson E.C. FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart Dev. Biol. 2007 304 308 316 10.1016/j.ydbio.2006.12.035 17274974 51. Plein A. Calmont A. Fantin A. Denti L. Anderson N.A. Scambler P.J. Ruhrberg C. Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation J. Clin. Inv. 2015 125 2661 2676 10.1172/JCI79668 52. Waller B.R. McQuinn T. Phelps A. Markwald R.R. Lo C.W. Thompson R.P. Wessels A. Conotruncal anomalies in the trisomy 16 mouse: An immunohistochemical analysis with emphasis on the involvement of the neural crest Anat. Rec. 2000 260 279 293 10.1002/1097-0185(20001101)260:3<279::AID-AR65>3.0.CO;2-2 11066038 53. Huang G.Y. Wessels A. Smith B.R. Linask K.K. Ewart J.L. Lo C.W. Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development Dev. Biol. 1998 198 32 44 10.1006/dbio.1998.8891 9640330 54. Rhee D.Y. Zhao X.Q. Francis R.J. Huang G.Y. Mably J.D. Lo C.W. Connexin 43 regulates epicardial cell polarity and migration in coronary vascular development Development 2009 136 3185 3193 10.1242/dev.032334 19700622 55. Ruiz-Villalba A. Hoppler S. van den Hoff M.J. Wnt signaling in the heart fields: Variations on a common theme Dev. Dyn. 2015 10.1002/dvdy.24372 26638115 56. Phillips H.M. Hildreth V. Peat J.D. Murdoch J.N. Kobayashi K. Chaudhry B. Henderson D.J. Non-cell-autonomous roles for the planar cell polarity gene Vangl2 in development of the coronary circulation Circ. Res. 2008 102 615 623 10.1161/CIRCRESAHA.107.160861 18174466 57. Phillips H.M. Murdoch J.N. Chaudhry B. Copp A.J. Henderson D.J. Vangl2 Acts via RhoA Signaling to Regulate Polarized Cell Movements During Development of the Proximal Outflow Tract Circ. Res. 2005 96 292 299 10.1161/01.RES.0000154912.08695.88 15637299 58. Henderson D.J. Phillips H.M. Chaudhry B. Vang-like 2 and noncanonical Wnt signaling in outflow tract development Trends Cardiovasc. Med. 2006 16 38 45 10.1016/j.tcm.2005.11.005 16473760 59. Gibbs B.C. Damerla R.R. Vladar E.K. Chatterjee B. Wan Y. Liu X. Cui C. Gabriel G.C. Zahid M. Yagi H. Prickle1 mutation causes planar cell polarity and directional cell migration defects associated with cardiac outflow tract anomalies and other structural birth defects Biol. Open 2016 5 323 335 10.1242/bio.015750 26883626 60. Qi C.H. Zhao X.Q. Ma D. Ma X.J. Zhou G.M. Huang G.Y. Downregulation of Rho associated coiled-coil forming protein kinase 1 in the process of delayed myocardialization of cardiac proximal outflow tract septum in connexin 43 knockout mice embryo Chin. Med. J. 2011 124 2021 2027 22088464 61. Nagy I.I. Railo A. Rapila R. Hast T. Sormunen R. Tavi P. Rasanen J. Vainio S.J. Wnt-11 signalling controls ventricular myocardium development by patterning N-cadherin and beta-catenin expression Cardiovasc. Res. 2010 85 100 109 10.1093/cvr/cvp254 19622544 62. Zhou W. Lin L. Majumdar A. Li X. Zhang X. Liu W. Etheridge L. Shi Y. Martin J. Van de Ven W. Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2 Nat. Genet. 2007 39 1225 1234 10.1038/ng2112 17767158 63. Schleiffarth J.R. Person A.D. Martinsen B.J. Sukovich D.J. Neumann A. Baker C.V. Lohr J.L. Cornfield D.N. Ekker S.C. Petryk A. Wnt5a is required for cardiac outflow tract septation in mice Pediatr. Res. 2007 61 386 391 10.1203/pdr.0b013e3180323810 17515859 64. Matsuda T. Nomi M. Ikeya M. Kani S. Oishi I. Terashima T. Takada S. Minami Y. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development Mech. Dev. 2001 105 153 156 10.1016/S0925-4773(01)00383-5 11429290 65. Yuan Y. Niu C.C. Deng G. Li Z.Q. Pan J. Zhao C. Yang Z.L. Si W.K. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells Int. J. Mol. Med. 2011 27 63 69 10.3892/ijmm.2010.560 21069266 66. Takeuchi S. Takeda K. Oishi I. Nomi M. Ikeya M. Itoh K. Tamura S. Ueda T. Hatta T. Otani H. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation Genes Cells 2000 5 71 78 10.1046/j.1365-2443.2000.00300.x 10651906 67. Nomi M. Oishi I. Kani S. Suzuki H. Matsuda T. Yoda A. Kitamura M. Itoh K. Takeuchi S. Takeda K. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: Redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases Mol. Cell Biol. 2001 21 8329 8335 10.1128/MCB.21.24.8329-8335.2001 11713269 68. Verkaar F. Zaman G.J. A model for signaling specificity of Wnt/Frizzled combinations through co-receptor recruitment FEBS Lett. 2010 584 3850 3854 10.1016/j.febslet.2010.08.030 20800062 69. DeRossi C. Laiosa M.D. Silverstone A.E. Holdener B.C. Mouse fzd4 maps within a region of chromosome 7 important for thymus and cardiac development Genesis 2000 27 64 75 10.1002/1526-968X(200006)27:2<64::AID-GENE30>3.0.CO;2-I 10890980 70. Hamblet N.S. Lijam N. Ruiz-Lozano P. Wang J. Yang Y. Luo Z. Mei L. Chien K.R. Sussman D.J. Wynshaw-Boris A. Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure Development 2002 129 5827 5838 10.1242/dev.00164 12421720 71. Hakim Z.S. DiMichele L.A. Doherty J.T. Homeister J.W. Beggs H.E. Reichardt L.F. Schwartz R.J. Brackhan J. Smithies O. Mack C.P. Conditional deletion of focal adhesion kinase leads to defects in ventricular septation and outflow tract alignment Mol. Cell. Biol. 2007 27 5352 5364 10.1128/MCB.00068-07 17526730 72. Armstrong P.B. Armstrong M.T. Intercellular invasion and the organizational stability of tissues: A role for fibronectin Biochim. Biophys. Acta 2000 1470 O9 O20 10.1016/S0304-419X(00)00003-2 10722930 73. Burns T.A. Dours-Zimmermann M.T. Zimmermann D.R. Krug E.L. Comte-Walters S. Reyes L. Davis M.A. Schey K.L. Schwacke J.H. Kern C.B. Imbalanced expression of Vcan mRNA splice form proteins alters heart morphology and cellular protein profiles PLoS ONE 2014 9 e89133 10.1371/journal.pone.0089133 24586547 74. Burns T. Yang Y. Hiriart E. Wessels A. The Dorsal Mesenchymal Protrusion and the Pathogenesis of Atrioventricular Septal Defects J. Cardiovasc. Dev. Dis. 2016 3 29 10.3390/jcdd3040029 28133602 75. Snarr B.S. O’Neal J.L. Chintalapudi M.R. Wirrig E.E. Phelps A.L. Kubalak S.W. Wessels A. Isl1 Expression at the Venous Pole Identifies a Novel Role for the Second Heart Field in Cardiac Development Circ. Res. 2007 101 971 974 10.1161/CIRCRESAHA.107.162206 17947796 76. Snarr B.S. Wirrig E.E. Phelps A.L. Trusk T.C. Wessels A. A spatiotemporal evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac development Dev. Dyn. 2007 236 1287 1294 10.1002/dvdy.21074 17265457 77. Kim J.S. Virágh S. Moorman A.F.M. Anderson R.H. Lamers W.H. Development of the myocardium of the atrioventricular canal and the vestibular spine in the human heart Circ. Res. 2001 88 395 402 10.1161/01.RES.88.4.395 11230106 78. Tian Y. Yuan L. Goss A.M. Wang T. Yang J. Lepore J.J. Zhou D. Schwartz R.J. Patel V. Cohen E.D. Characterization and in vivo pharmacological rescue of a Wnt2-Gata6 pathway required for cardiac inflow tract development Dev. Cell 2010 18 275 287 10.1016/j.devcel.2010.01.008 20159597 79. Briggs L.E. Phelps A.L. Brown E. Kakarla J. Anderson R.H. van den Hoff M.J. Wessels A. Expression of the BMP Receptor Alk3 in the Second Heart Field is Essential for Development of the Dorsal Mesenchymal Protrusion and Atrioventricular Septation Circ. Res. 2013 112 1420 4132 10.1161/CIRCRESAHA.112.300821 23584254 80. Briggs L.E. Burns T.A. Lockhart M.M. Phelps A.L. van den Hoff M.J. Wessels A. The Wnt/beta-catenin and Sonic Hedgehog pathways interact in the regulation of the development of the Dorsal Mesenchymal Protrusion Dev. Dyn. 2016 245 103 113 10.1002/dvdy.24339 26297872 81. van Vliet P.P. Lin L. Boogerd C.J. Martin J.F. Andelfinger G. Grossfeld P.D. Evans S.M. Tissue specific requirements for WNT11 in developing outflow tract and dorsal mesenchymal protrusion Dev. Biol. 2017 429 249 259 10.1016/j.ydbio.2017.06.021 28669819 82. Li D. Angermeier A. Wang J. Planar cell polarity signaling regulates polarized second heart field morphogenesis to promote both arterial and venous pole septation Development 2019 146 dev181719 10.1242/dev.181719 31488563 83. Gunthel M. Barnett P. Christoffels V.M. Development, Proliferation, and Growth of the Mammalian Heart Mol. Ther. 2018 26 1599 1609 10.1016/j.ymthe.2018.05.022 29929790